AOPS reaches 1.77 million verified healthcare professionals worldwide, including 1.05 million in the United States. Our panels cover 16 therapeutic areas, from oncology and cardiology through to rare disease and cell and gene therapy, plus nurses, pharmacists and hospital leadership.
Reach by region
| Region | Verified healthcare professionals |
|---|---|
|
Global |
1,770,000 |
|
United States |
1,050,000 |
|
UK and EU |
724,000 |
Our own panel first
Around 85% of completes come from our core panel asset.
Beyond that we work with roughly 12 core partners across the US, EU4, UK and Canada, and a vetted network up to 20 deep depending on the geography and respondent type.
We are panel-agnostic, which means we buy whatever sample your study genuinely needs rather than whatever we happen to own. But most of the time, we own it.
Therapeutic areas
Comprehensive coverage
- Oncology and cancer
- Rare diseases and orphan
- Cardiovascular disease
- Infectious diseases
- Neurology and neurodegenerative
- Respiratory disease
- Endocrinology and metabolic
- Dermatology
Specialized areas
- Cell and gene therapy
- Pain management
- Vaccines and prevention
- Psychiatry and mental health
- Women’s and men’s health
- Ophthalmology
- Pediatric diseases
- Transplantation
Audiences we reach
Physicians and specialists. Across all 16 therapeutic areas above, from high-volume primary care through to subspecialists.
Nurses and allied health professionals. Nurse practitioners, physician assistants, specialist nurses and allied disciplines.
Pharmacists. Retail, hospital and specialty.
Hospital administration and leadership. [NEEDS AOPS: confirm whether you reach C-suite, medical directors, formulary and procurement decision-makers. Competitors quantify this, for example “150,000+ hospital administrators”.]
Hard-to-reach and low-incidence audiences. Rare disease specialists, emerging therapy areas and niche subspecialties.
Typical study sizes
| Study type | Typical size |
|---|---|
|
US quantitative |
135 to 150 completes |
|
US qualitative |
15 to 25 interviews (largest to date: 84) |
|
Global quantitative |
~150 in the US plus 150 across international markets |
|
Global qualitative |
~15 in the US plus 5 to 8 per international market |
Frequently asked questions
We reach 1.77 million verified healthcare professionals worldwide, including 1.05 million in the United States and 724,000 across the UK and EU.
Around 85% of completes come from our own core panel. The remainder comes from roughly 12 vetted core partners, used where geography or a low-incidence audience requires it.
Sixteen, spanning oncology, cardiovascular, neurology, endocrinology, rare disease, infectious disease, respiratory, dermatology, cell and gene therapy, vaccines, women’s and men’s health, pediatrics, pain management, psychiatry, ophthalmology and transplantation.
Yes. Our panels include nurses, nurse practitioners, physician assistants, allied health professionals and pharmacists across retail, hospital and specialty settings.
Yes. We field across the US, EU4, UK and Canada through our core network, with wider reach through vetted partners.